UK approves anti-inflammatory drugs to treat sickest Covid-19 patients after strong results in clinical trial


WBHM - This proof-of concept study suggests that the strategy of blocking virus with antibodies holds promise. Inmaculada “Inma” Hernandez (HPM ’16), Pitt School of Pharmacy, is hopeful, but she doubts that these drugs will be a game-changer. “These drugs are so complex to produce, probably we will not have antibodies available for treating everybody who gets coronavirus. They’re probably going to be considerably expensive.”

Read full story


Search for an Article